CAPE FEAR VALLEY HOKE HOSPITAL
1. Target Overview & Investment Thesis
CAPE FEAR VALLEY HOKE HOSPITAL is a 41-bed suburban community hospital in HOKE, NC with $71.5M in net patient revenue and a 19.3% operating margin. The hospital serves a payer mix of 24.1% Medicare, 4.1% Medicaid, and 71.8% commercial.
Thesis: Turnaround. Our ML models identify $5.3M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 19.3% to 26.7% (+736bps).
| Net Revenue HCRIS | $71.5M |
| Current EBITDA COMPUTED | $13.8M |
| Operating Margin COMPUTED | 19.3% |
| Occupancy HCRIS | 36.4% |
| Revenue / Bed COMPUTED | $1.7M |
| Net-to-Gross HCRIS | 27.6% |
| Distress Probability ML | 49.9% |
2. Market Context & Competitive Position
NC has 129 Medicare-certified hospitals with a median operating margin of -2.0%. The target's margin of 19.3% places it above the state median. Among 50 size-comparable peers (20-82 beds), the median margin is -4.1%. The target performs in line with or above peers.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (20-82), prioritizing same-state peers. 50 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| CAPE FEAR VALLEY HOKE HOSPITAL (Target) | NC | 41 | $71.5M | 19.3% |
| ADVENTHEALTH HENDERSONVILLE | NC | 73 | $227.1M | -4.1% |
| THOMASVILLE MEDICAL CENTER | NC | 73 | $220.3M | -14.3% |
| BRUNSWICK COMMUNITY HOSPITAL | NC | 65 | $143.2M | 12.9% |
| LEXINGTON MEMORIAL HOSPITAL I | NC | 70 | $138.3M | 6.9% |
| WRMC HOSPITAL OPERATING CORPOR | NC | 77 | $120.6M | 0.7% |
| HUGH CHATHAM MEMORIAL HOSPITAL | NC | 81 | $115.6M | -10.7% |
| HARRIS REGIONAL HOSPITAL | NC | 82 | $113.2M | -6.1% |
| DAVIE MEDICAL CENTER | NC | 42 | $108.5M | 27.5% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $5.3M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $1.5M | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $1.4M | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $1.4M | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $870K | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $46K | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $13.8M |
| + RCM Uplift | +$5.3M |
| Pro Forma EBITDA | $19.1M |
| Current Margin | 19.3% |
| Pro Forma Margin | 26.7% |
| WC Released (1x) | $2.7M |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $21.3M | $143.8M | 6.76x | 46.6% |
| Base (11x exit) | 10.0x | 11.0x | $21.3M | $165.1M | 7.76x | 50.7% |
| Bull Case | 9.0x | 11.0x | $19.1M | $189.4M | 9.89x | 58.1% |
| Bull (12x exit) | 9.0x | 12.0x | $19.1M | $212.3M | 11.09x | 61.8% |
| Bear Case | 11.0x | 10.0x | $23.4M | $110.6M | 4.73x | 36.4% |
| Bear (11x exit) | 11.0x | 11.0x | $23.4M | $129.3M | 5.53x | 40.8% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| Medium | Standard execution risk | RCM improvement requires management buy-in and 12-18 month implementation timeline |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 50 hospitals with 20-82 beds
- Same-state prioritization (n=51)
- Comp margins: P25=-16.1% / P50=-4.1% / P75=5.3%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 27, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.